Is retatrutide illegal in Europe?

Selling it is. Retatrutide has no marketing authorisation anywhere, and Article 6(1) of Directive 2001/83/EC prohibits placing an unauthorised medicinal product on the market in every EU member state. Whether possessing it is an offence is decided nationally and differs: in Germany, France and Spain mere possession for personal use is not an offence, while Dutch law is drafted more broadly.

Can I be prosecuted for buying retatrutide in Europe?

Across the four countries researched in detail, Germany, France, Spain and the Netherlands, no prosecution of a private individual for personal-use purchase or possession could be documented. Enforcement targets sellers, websites, importers and production facilities. What buyers do experience is seizure of the parcel and loss of the money paid.

Can I order retatrutide by post to my country?

There is no compliant postal route in any of the four countries researched. Germany prohibits it under section 73 of its medicines act with fines up to 25,000 euros. France requires an import authorisation that an unauthorised drug cannot obtain. Spain permits no personal medicine import by post. Dutch law exempts only medicines carried by the traveller, which a parcel is not.

GLP1 Europe › Legality in Europe

Is retatrutide legal in your country?

Last checked 14 August 2026 · Four countries verified in detail · Not legal advice

Short answer

Selling it is illegal in every European country. Retatrutide has no marketing authorisation anywhere in the world, and every EU member state prohibits placing an unauthorised medicine on the market. That part does not vary.

What it means for a private individual does vary, and by more than most people expect. In Germany, France and Spain, simply possessing it is not an offence. Dutch law is drafted so broadly that even holding one is prohibited. Every country blocks the postal route.

What is the same everywhere

Two provisions of the same EU directive are transposed into the national law of all 27 member states, which is why the selling answer does not change as you cross a border.

Article 6(1) of Directive 2001/83/EC: no medicinal product may be placed on the market without a marketing authorisation. Retatrutide has none, anywhere.

Article 87(1): advertising a medicine that has no marketing authorisation is prohibited. Note that this one bans advertising to anyone, not only to the public, which is why seller websites are the thing regulators move against first.

A "research use only" label changes neither, because EU law classifies a product by how it is presented and what it does, not by what its label says. The full legal position on that label is here.

The four countries verified in detail

Legal position for a private individual, verified 14 August 2026
Country	Selling	Possessing	Ordering by post
GermanyAMG	Criminalup to 1 year	Not an offence	Prohibitedfines to €25,000
FranceCode de la santé publique	Criminalup to 7 years via a website	Not penalised	No legal route
SpainRDL 1/2015	Up to €1,000,000plus criminal exposure	Not sanctioned	No legal route
NetherlandsGeneesmiddelenwet	Criminalup to 6 years	Prohibitedstrictest of the four	No legal route

"Not an offence" means the national statute does not penalise possession itself. It does not mean the substance is legal, that acquiring it is lawful, or that a parcel will reach you.

Who actually gets prosecuted

This is the part that rarely gets written down accurately, so here it is plainly. Across all four countries, we could not document a single prosecution of a private individual for buying or possessing these substances for personal use. Every documented action was against supply: France targeted around ten selling platforms and referred cases to prosecutors, the UK raided production facilities, Spain dismantled a distribution network with 33 arrests.

What buyers do experience is the parcel being seized and the money being gone. In Germany, defence practitioners report that buyers often first learn of a proceeding when the seizure notice arrives, and the documented outcome for personal quantities is an administrative fine.

None of that is a prediction about any particular case, and enforcement priorities change. It is a description of the record as it stands.

Common questions

Why is possession legal if selling is not?: Because the EU directive regulates placing products on the market, and that is what member states transposed. Most did not add a possession offence for ordinary medicines, unlike controlled drugs, where possession is criminalised separately. The Netherlands is the outlier, having drafted its prohibition to include holding an unauthorised medicine in stock.
My country is not on the list. What applies to me?: The EU baseline above applies in every member state: selling and advertising an unauthorised medicine are prohibited. The national questions, whether possession is an offence and how customs handles parcels, genuinely vary, and we will not guess at them. Pick your country in the form and we will prioritise researching it.
Does it matter that it is labelled for research?: No. Both limbs of the EU definition of a medicine ignore labelling: one looks at how a product is presented, the other at whether it has a pharmacological effect, which a GLP-1 agonist does by definition. Germany's Federal Court of Justice settled the labelling point in 2009 in a case about a solvent sold as wheel cleaner.

Sources

Directive 2001/83/EC, consolidated text, Articles 1(2), 6(1) and 87(1).
Germany: Arzneimittelgesetz, sections 21, 73, 96 and 97; German customs guidance on medicines in postal consignments; Bundesgerichtshof, 8 December 2009, 1 StR 277/09.
France: Code de la santé publique, articles L5121-8 and L5421-2; ANSM enforcement actions 2025 and 2026.
Spain: Real Decreto Legislativo 1/2015, articles 9.1, 111 and 114; Código Penal article 361; Ministry of the Interior, network dismantled 27 June 2025.
Netherlands: Geneesmiddelenwet articles 18 and 40; Wet op de economische delicten.
Full citations are on each country page.

This page summarises published law and documented enforcement on the date shown. It is not legal advice, it can lag changes, and how the law applies to any particular person is a question for a lawyer qualified in that country. Nothing here should be read as encouraging the purchase of an unauthorised medicine.